Two-to-Five-Year Follow-Up of 19 Workers Meeting Mathias Criteria
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Reader question: What can this study tell workers, families and occupational-health teams—and what would go beyond the evidence? This review keeps every number attached to its population, denominator, comparator and timepoint.
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 19 patients with contact dermatitis who met at least four Mathias occupational-causation criteria and changed or stopped the implicated work. |
| Design | Small longitudinal re-examination study evaluating a clinical attribution framework. |
| Comparator | Dermatitis status after leaving or changing the prior workplace relative to the earlier positive occupational assessment. |
| Timepoint | Two to five years after workplace change or work cessation. |
| Key result | Fourteen of 19 patients (74%) reported clearance after leaving the previous workplace. Five still had dermatitis; three of those five may have encountered causative allergens at the new workplace. |
| Funding/conflict context | No grant or conflict-of-interest statement appears in the PubMed record retrieved for this review. |
What was actually measured?
Fourteen of 19 patients (74%) reported clearance after leaving the previous workplace. Five still had dermatitis; three of those five may have encountered causative allergens at the new workplace.
Improvement after exposure cessation is one element supporting occupational attribution. The result is consistent with the criteria's purpose but does not independently validate every component.
The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.
What the result does not prove
Very small selected sample, self-reported clearance, no control group and possible new exposures. Regression to the mean and treatment changes cannot be separated from workplace change.
Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.
Exposure detail matters more than the job label
Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.
A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.
Questions worth recording
- Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
- Where did the change begin, and did it improve on days away or after a process or PPE change?
- How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
- Were labels, ingredient information and safety-data sheets reviewed with occupational health?
- Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?
Prevention comes before cosmetic care
Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.
Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.
Primary research and guidance
- Primary research record: PubMed PMID 15291825
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Four Dermatitis Assessments Across 751 Construction Workers
- Validating Functional-Disability Scores in 422 Dermatitis Patients
- Metalworking-Fluid Sensitization in 160 Exposed Metalworkers
- Occupational Skin-Disease Reports in 706 Nurses
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.